Immunotherapy of cancer using IL-2.
Berd
D
D
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology
D000970:Antineoplastic Agents; D007376:Interleukin-2